*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Clinical stage stem cell business ReNeuron Group has won a £1. 5m grant to advance development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina.
Beleaguered mother and child retailer Mothercare announced the departure of chairman Alan Parker on Thursday, hot on the heels of the appointment of a new chief executive earlier this month.
Debenhams profits plunged 85% in the first half of its financial year as like-for-like sales slipped amid the "challenging UK market background" and heavy snow, while finance director jumped ship to join a department store rival.
